Methods of diagnostic screening and early detection of adenomyosis
AssigneeArizona Board of Regents on Behalf of the University of Arizona
InventorsMelissa M. Herbst-Kralovetz, Pawel Laniewski
Life of this patent
Estimating the term…
Loading patent…
AssigneeArizona Board of Regents on Behalf of the University of Arizona
InventorsMelissa M. Herbst-Kralovetz, Pawel Laniewski
Estimating the term…
Adenomyosis is a highly prevalent yet enigmatic disease that can be diagnosed only via histopathology among women undergoing hysterectomy, thus, leading to underdiagnosis. Unfortunately, research on adenomyosis has been limited due to a variety of challenges, and little work has been done on non-invasive diagnostics for adenomyosis. Currently, there is no FDA-approved non-invasive method for early detection of adenomyosis. By integrating immunoassays and metabolomics analyses, candidate biomarkers for the non-invasive diagnosis of adenomyosis in cervicovaginal lavages have been identified. Thus, methods for non-invasive diagnostic, screening, and early detection of adenomyosis in patients are described herein.
A non-invasive method of diagnosing a benign gynecologic condition in a patient, the method comprising:
A method of treating a benign gynecologic condition in a patient in need thereof, the method comprising:
A method of distinguishing between adenomyosis and endometriosis in a subject, the method comprising:
Dependencies are inferred from the claim text.